It has been proposed that the nigrostriatal dopaminergic abnormalities arise secondary to dysfunction in cortical circuits; this proposes that lower cortical glutamate and NMDA receptor levels lead to reduced activation of cortical GABA interneurons regulating glutamatergic projection neurons into the striatum, as shown in the figure.1,2

Imaging studies indicate higher striatal dopamine, which has been linked to psychotic symptoms.2

Lower cortical levels of glutamate and GABA underpin an excitation/inhibition imbalance, which has been linked to both cognitive deficits and negative symptoms.2

This helps explain why dopamine-targeting treatments improve psychosis but often have limited effects on negative symptoms and cognition, as these are likely reflecting upstream cortical glutamatergic, and GABAergic dysfunction.2

GABA=gamma-aminobutyric acid; NDMA=N-methyl-D-aspartate

file_download Download in HQ

Related content

image Image Brain diagram showing cholinergic pathways originating from basal forebrain and brainstem nuclei and projecting to cortical and subcortical regions
Cholinergic projections in the central nervous system

Cholinergic projections connect key brain regions involved in cognition, memory, attention, and neurotransmitter regulation.

05.08.2026 Schizophrenia
image Image Diagram illustrating how genetic, environmental, and neurobiological factors interact through stress and dopamine dysregulation to contribute to psychosis
Interactions leading to psychosis

Genetic vulnerability, environmental risk factors, and dopamine dysregulation interact to drive the development of psychosis.

05.08.2026 Schizophrenia
image Image Heatmap showing genetic correlations among psychiatric disorders, including schizophrenia, bipolar disorder, depression, anxiety, PTSD, alcoholism, and insomnia
Genetic overlap across psychiatric disorders

Psychiatric disorders share substantial genetic risk, with particularly strong overlap observed between schizophrenia, bipolar disorder, depression, anxiety, and PTSD.

05.08.2026 Schizophrenia